IRIS UniCatt

Tortora, Giampaolo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.915
AS - Asia 5.513
EU - Europa 4.186
SA - Sud America 1.488
AF - Africa 184
OC - Oceania 33
Continente sconosciuto - Info sul continente non disponibili 6
Totale 17.325
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.688
SG - Singapore 2.614
BR - Brasile 1.247
CN - Cina 1.156
IT - Italia 1.016
SE - Svezia 913
DE - Germania 514
IN - India 416
VN - Vietnam 410
FR - Francia 338
GB - Regno Unito 255
IE - Irlanda 235
ID - Indonesia 208
PL - Polonia 207
FI - Finlandia 178
HK - Hong Kong 121
RU - Federazione Russa 121
CA - Canada 114
BD - Bangladesh 91
AR - Argentina 82
NL - Olanda 79
KR - Corea 77
MX - Messico 70
AT - Austria 68
JP - Giappone 65
TR - Turchia 63
EC - Ecuador 58
ZA - Sudafrica 57
ES - Italia 55
IQ - Iraq 51
CI - Costa d'Avorio 41
PK - Pakistan 35
UA - Ucraina 34
IR - Iran 32
CZ - Repubblica Ceca 29
AU - Australia 27
BE - Belgio 26
VE - Venezuela 26
SA - Arabia Saudita 24
CO - Colombia 23
UZ - Uzbekistan 22
LT - Lituania 21
CH - Svizzera 18
PH - Filippine 18
EG - Egitto 17
KE - Kenya 17
JO - Giordania 16
MA - Marocco 16
CL - Cile 13
IL - Israele 13
AE - Emirati Arabi Uniti 12
PY - Paraguay 11
RO - Romania 11
UY - Uruguay 10
GR - Grecia 9
MY - Malesia 9
PE - Perù 9
AZ - Azerbaigian 8
BO - Bolivia 8
TN - Tunisia 8
TW - Taiwan 8
HN - Honduras 7
KZ - Kazakistan 7
LV - Lettonia 7
AL - Albania 6
BG - Bulgaria 6
CR - Costa Rica 6
NZ - Nuova Zelanda 6
PA - Panama 6
RS - Serbia 6
TT - Trinidad e Tobago 6
DZ - Algeria 5
HU - Ungheria 5
LU - Lussemburgo 5
PT - Portogallo 5
TH - Thailandia 5
BY - Bielorussia 4
CY - Cipro 4
DO - Repubblica Dominicana 4
GE - Georgia 4
JM - Giamaica 4
LB - Libano 4
NG - Nigeria 4
NP - Nepal 4
SN - Senegal 4
BJ - Benin 3
ET - Etiopia 3
EU - Europa 3
HR - Croazia 3
NI - Nicaragua 3
PS - Palestinian Territory 3
XK - ???statistics.table.value.countryCode.XK??? 3
BB - Barbados 2
DK - Danimarca 2
GT - Guatemala 2
KG - Kirghizistan 2
KW - Kuwait 2
MD - Moldavia 2
MM - Myanmar 2
SK - Slovacchia (Repubblica Slovacca) 2
Totale 17.299
Salva come PNG Salva come JPEG
Città #
Singapore 1.338
Ashburn 1.227
Chandler 684
Rome 307
Beijing 289
New York 233
Hyderabad 230
Dublin 228
Hefei 222
Los Angeles 201
Warsaw 187
Fairfield 167
Jakarta 161
Ho Chi Minh City 147
Milan 142
Munich 133
São Paulo 123
Frankfurt am Main 121
Chicago 119
The Dalles 119
Hong Kong 116
Wilmington 109
Hanoi 104
Princeton 103
Houston 98
Boston 88
Seattle 88
Helsinki 86
San Mateo 76
Seoul 75
Dallas 73
Moscow 66
Kent 64
Tokyo 60
Woodbridge 59
London 58
Nuremberg 56
Marseille 55
Cambridge 53
Cattolica 50
Turku 46
Boardman 45
Brooklyn 43
Lappeenranta 43
Santa Clara 43
Buffalo 42
Düsseldorf 42
Abidjan 41
Ann Arbor 40
Denver 39
Vienna 39
Stockholm 37
Chennai 36
Johannesburg 36
Rio de Janeiro 34
Bremen 33
North Bergen 31
Toronto 31
Mexico City 30
Phoenix 30
Curitiba 29
Montreal 29
Orem 29
Poplar 29
Lauterbourg 28
Amsterdam 27
Atlanta 26
Brussels 24
Matera 24
Nanjing 24
Bexley 23
Guayaquil 23
Manchester 23
Dhaka 22
Augusta 21
Dearborn 21
Salt Lake City 21
Belo Horizonte 20
Falkenstein 20
Mumbai 20
Naples 20
Brno 19
Council Bluffs 19
Goiânia 19
Porto Alegre 19
Portsmouth 19
Tashkent 19
Washington 19
Baghdad 18
Redwood City 18
Ankara 17
Brasília 17
Paris 17
Amman 16
Campinas 16
Quito 16
Haiphong 15
Kish 15
Tampa 15
Norwalk 14
Totale 9.506
Salva come PNG Salva come JPEG
Nome #
Discordance of KRAS Mutational Status between Primary Tumors and Liver Metastases in Colorectal Cancer: Impact on Long-Term Survival Following Radical Resection 590
Pembrolizumab as first-line treatment for metastatic uveal melanoma 319
C-myc expression is a possible keystone in the colorectal cancer resistance to egfr inhibitors 279
A digital solution to support the activities: Multidisciplinary Tumor Board process and impact analysis 251
Gene Expression Profiling of Lung Atypical Carcinoids and Large Cell Neuroendocrine Carcinomas Identifies Three Transcriptomic Subtypes with Specific Genomic Alterations 233
Translational Research in the Era of Precision Medicine: Where We Are and Where We Will Go 206
Diagnosis and treatment of bone metastases in breast cancer: Radiotherapy, local approach and systemic therapy in a guide for clinicians 200
c-MYC Expression Is a Possible Keystone in the Colorectal Cancer Resistance to EGFR Inhibitors. 178
Impact of muscle mass loss on outcomes in advanced or metastatic gastric cancer patients receiving a second-line treatment 171
Development of a digital research assistant for the management of patients’ enrollment in oncology clinical trials within a research hospital 171
The impact of the multidisciplinary tumor board (MDTB) on the management of pancreatic diseases in a tertiary referral center 153
Liver metastasectomy for metastatic breast cancer patients: A single institution retrospective analysis 153
191P Radiotherapy (RT) in oligoprogressive metastatic breast cancer (mBC): A retrospective analysis 142
Lung cancer multi-omics digital human avatars for integrating precision medicine into clinical practice: the LANTERN study 141
Gut microbiome, big data and machine learning to promote precision medicine for cancer 137
Liver metastasectomy for metastatic breast cancer patients: A single institution retrospective analysis 137
Safety and efficacy of endoscopic ultrasound-guided radiofrequency ablation for pancreatic insulinoma: A single-center experience 136
Blood serum amyloid A as potential biomarker of pembrolizumab efficacy for patients affected by advanced non-small cell lung cancer overexpressing PD-L1: results of the exploratory “FoRECATT” study 136
Management of the kidney transplant patient with Cancer: Report from a Multidisciplinary Consensus Conference 135
Challenges in crohn’s disease management after gastrointestinal cancer diagnosis 134
Management of the kidney transplant patient with Cancer: Report from a Multidisciplinary Consensus Conference 133
Targeted next-generation sequencing identifies genomic abnormalities potentially driving the prognosis of early-stage invasive lobular breast carcinoma patients stratified according to a validated clinico-pathological model 131
An alternative splicing signature defines the basal-like phenotype and predicts worse clinical outcome in pancreatic cancer 130
Immunotherapy and radiotherapy in melanoma: a multidisciplinary comprehensive review 130
Management of single pulmonary metastases from colorectal cancer: State of the art 129
Clinical, pathological and prognostic features of rare braf mutations in metastatic colorectal cancer (Mcrc): A bi-institutional retrospective analysis (rebus study) 127
Intratumoral injection of TLR9 agonist promotes an immunopermissive microenvironment transition and causes cooperative antitumor activity in combination with anti-PD1 in pancreatic cancer 126
Identification of spatially-resolved markers of malignant transformation in Intraductal Papillary Mucinous Neoplasms 122
Body composition changes in gastric cancer patients during preoperative flot therapy: Preliminary results of an italian cohort study 121
Dynamics of RAS/BRAF Mutations in cfDNA from Metastatic Colorectal Carcinoma Patients Treated with Polychemotherapy and Anti-EGFR Monoclonal Antibodies 121
BRCA Mutation Status in Triple-Negative Breast Cancer Patients Treated with Neoadjuvant Chemotherapy: A Pivotal Role for Treatment Decision-Making 119
Radiotherapy benefit in oligoprogressive breast cancer: A retrospective analysis 119
Let‐7a‐5p, mir‐100‐5p, mir‐101‐3p, and mir‐199a‐3p hyperexpression as potential predictive biomarkers in early breast cancer patients 119
Benefit of a multimodal approach combining chemotherapy and surgery in oligometastatic gastric cancer: experience from a tertiary referral center 117
Development of a digital research assistant for the management of patients’ enrollment in oncology clinical trials within a research hospital 113
Conversion Therapy With Encorafenib and Cetuximab for Chemo-Refractory BRAF V600E-Mutated Liver-Limited Colorectal Cancer Metastasis: The First Case Report 113
Nutritional Interventions during Chemotherapy for Pancreatic Cancer: A Systematic Review of Prospective Studies 112
Hepatic Radiotherapy in Addition to Anti-PD-1 for the Treatment of Metastatic Uveal Melanoma Patients 111
The likelihood of being helped or harmed as a patient-centred tool to assess cyclin dependent kinase 4/6 inhibitors clinical impact and safety in metastatic breast cancer: a systematic review and sensitivity-analysis 111
PTEN Loss as a Predictor of Tumor Heterogeneity and Poor Prognosis in Patients With EGFR-mutant Advanced Non–small-cell Lung Cancer Receiving Tyrosine Kinase Inhibitors 111
Nutritional Interventions during Chemotherapy for Pancreatic Cancer: A Systematic Review of Prospective Studies 110
Skeletal Muscle Loss during Multikinase Inhibitors Therapy: Molecular Pathways, Clinical Implications, and Nutritional Challenges. 110
CXCR1/2 dual-inhibitor ladarixin reduces tumour burden and promotes immunotherapy response in pancreatic cancer 109
Symptomatic androgen deficiency and sexual dysfunctions in male patients receiving alectinib for ALK-positive advanced nonsmall cell lung cancer 109
Impact of Comprehensive Genome Profiling on the Management of Advanced Non–Small Cell Lung Cancer: Preliminary Results From the Lung Cancer Cohort of the FPG500 Program 108
Palbociclib plus fulvestrant or everolimus plus exemestane for pretreated advanced breast cancer with lobular histotype in er+/her2− patients: A propensity score-matched analysis of a multicenter retrospective patient series 108
Body composition derangements in lung cancer patients treated with first-line pembrolizumab: A multicentre observational study 107
Immunological backbone of uveal melanoma: Is there a rationale for immunotherapy? 106
Skin cancer triage and management during COVID-19 pandemic. 106
Immune-checkpoint inhibitors in renal transplanted patients affected by melanoma: A systematic review 105
Muscle mass, assessed at diagnosis by L3-CT scan as a prognostic marker of clinical outcomes in patients with gastric cancer: A systematic review and meta-analysis. 104
Dabrafenib-Trametinib and Radiotherapy for Oligoprogressive BRAF Mutant Advanced Melanoma 103
Dabrafenib and Trametinib in BRAF Mutant Metastatic Conjunctival Melanoma 103
Comparison of first-line chemotherapy regimens in unresectable locally advanced or metastatic pancreatic cancer: a systematic review and Bayesian network meta-analysis 102
Effects of nutritional interventions on nutritional status in patients with gastric cancer: A systematic review and meta-analysis of randomized controlled trials 101
Mutational status of plasma exosomal KRAS predicts outcome in patients with metastatic colorectal cancer 101
Large Cell Neuro-Endocrine Carcinoma of the Lung: Current Treatment Options and Potential Future Opportunities 100
Conjunctival melanoma: Genetic and epigenetic insights of a distinct type of melanoma 100
Novel epigenetic eight-gene signature predictive of poor prognosis and msi-like phenotype in human metastatic colorectal carcinomas 100
Surgery for locally advanced gastric cancer in the era of neoadjuvant therapies: something new? 99
Integrating a Comprehensive Cancer Genome Profiling into Clinical Practice: A Blueprint in an Italian Referral Center 99
Role of chemoradiation (CRT) in the adjuvant treatment of radically resected pancreatic cancer (PC) patients (pts): a mono-institutional retrospective analysis 99
Bevacizumab as maintenance therapy in patients with metastatic colorectal cancer: A meta-analysis of individual patients’ data from 3 phase III studies 99
Oncogene-addicted non-small-cell lung cancer: Treatment opportunities and future perspectives 99
Going towards a precise definition of the therapeutic management of de-novo metastatic castration sensitive prostate cancer patients: How prognostic classification impact treatment decisions 97
Biomarkers of response to advanced prostate cancer therapy 95
Preoperative low skeletal muscle mass index assessed using L3-CT as a prognostic marker of clinical outcomes in pancreatic cancer patients undergoing surgery: A systematic review and meta-analysis. 94
Accessible model predicts response in hormone receptor positive HER2 negative breast cancer receiving neoadjuvant chemotherapy 94
PD-L1 for selecting non-small-cell lung cancer patients for first-line immuno-chemotherapy combination: A systematic review and meta-analysis 94
Mutational status of plasma exosomal KRAS predicts outcome in patients with metastatic colorectal cancer 94
Challenges in Crohn's Disease Management after Gastrointestinal Cancer Diagnosis 93
Codon-specific KRAS mutations predict survival benefit of trifluridine/tipiracil in metastatic colorectal cancer 93
The effect of a treatment delay on outcome in metastatic renal cell carcinoma 93
Impact on survival of primary tumor resection in patients with metastatic breast cancer: preliminary results of a retrospective analisys 93
An IT Platform Supporting Rectal Cancer Tumor Board Activities: Implementation Process and Impact Analysis 93
Faecal microbiota transplantation for the treatment of diarrhoea induced by tyrosine-kinase inhibitors in patients with metastatic renal cell carcinoma 92
Neoadjuvant treatment: A window of opportunity for nutritional prehabilitation in patients with pancreatic ductal adenocarcinoma 92
The Impact of a Multidisciplinary Tumor Board (MDTB) in the Management of Colorectal Cancer (CRC) 90
Contemporary Analysis of cardiac Tamponade Etiologies, Treatments, and Outcomes: the CATEO Study 90
PD-L1 Expression in de Novo Metastatic Castration-sensitive Prostate Cancer 90
Dupilumab-associated ocular adverse events are predicted by low tear break-up time and correlate with high IL-33 tear concentrations in patients with atopic dermatitis 89
Theranostics revolution in prostate cancer: Basics, clinical applications, open issues and future perspectives 89
Prognostic factors affecting survival after pulmonary resection of metastatic renal cell carcinoma: A multicenter experience 89
Nutritional Support in Lung Cancer Patients: The State of the Art 88
Clinical Stage III NSCLC Patients Treated with Neoadjuvant Therapy and Surgery: The Prognostic Role of Nodal Characteristics 87
Adjuvant nab-Paclitaxel + Gemcitabine in Resected Pancreatic Ductal Adenocarcinoma: Results from a Randomized, Open-Label, Phase III Trial 87
Post-traumatic growth in oncological patients during the COVID-19 pandemic 87
Exploring the molecular and biological background of lung neuroendocrine tumours 87
Prognostic Model for Resected Squamous Cell Lung Cancer: External Multicenter Validation and Propensity Score Analysis exploring the Impact of Adjuvant and Neoadjuvant Treatment 87
Evidence-based tailored nutrition educational intervention improves adherence to dietary guidelines, anthropometric measures and serum metabolic biomarkers in early-stage breast cancer patients: A prospective interventional study 87
Role of Chemoradiation in the Adjuvant Treatment of Radically Resected Pancreatic Cancer Patients: A Mono-Institutional Retrospective Analysis 86
Advances towards the design and development of personalized non-small-cell lung cancer drug therapy 85
Development of a nomogram for predicting pathological complete response in luminal breast cancer patients following neoadjuvant chemotherapy 84
Targeting hypoxia-inducible factor pathways in sporadic and Von Hippel-Lindau syndrome-related kidney cancers 84
Percutaneous radiofrequency ablation using internally cooled wet electrodes for the treatment of patients with lung tumors 84
Efficacy of immune checkpoint inhibitors in different types of melanoma 84
Talniflumate abrogates mucin immune suppressive barrier improving efficacy of gemcitabine and nab-paclitaxel treatment in pancreatic cancer 83
Cabozantinib-related cardiotoxicity: a prospective analysis in a real-world cohort of metastatic renal cell carcinoma patients 83
Endoscopic ultrasound-guided therapies for pancreatic solid tumors: An overview 83
Efficacy of third-line anti-EGFR-based treatment versus regorafenib or trifluridine/tipiracil according to primary tumor site in RAS/BRAF wild-type metastatic colorectal cancer patients 83
Totale 12.107
Salva come PNG Salva come JPEG
Categoria #
all - tutte 80.020
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 80.020
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021261 0 0 0 0 0 15 32 4 49 51 78 32
2021/20221.056 123 40 26 111 44 38 19 134 50 35 225 211
2022/20232.290 327 288 166 313 127 253 139 164 227 82 100 104
2023/20242.118 59 321 81 88 85 201 366 321 45 82 185 284
2024/20254.517 96 84 319 158 273 153 269 154 579 660 906 866
2025/20266.533 1.414 507 824 1.760 1.944 84 0 0 0 0 0 0
Totale 17.626